Dyadic International, Sanofi, EnGen Bio deal

Dyadic said Sanofi’s Sanofi Pasteur S.A. vaccines unit will terminate a 2011 collaboration with Dyadic and EnGen to develop Dyadic’s C1 fungal expression technology for vaccine indications. The termin...